» Articles » PMID: 32325026

Endothelial Cell Infection and Endotheliitis in COVID-19

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2020 Apr 24
PMID 32325026
Citations 3531
Authors
Affiliations
Soon will be listed here.
Citing Articles

CircSARS-CV2-N1368 from SARS-CoV-2 impairs endothelial cell function through the upregulation of ATF7 to activate TLR4/NF-κB/ROS signaling.

Wen Y, Zhao H, Wu S, Jiang J, Gao Y, Wang Z Acta Pharmacol Sin. 2025; .

PMID: 40069492 DOI: 10.1038/s41401-025-01516-8.


Late pandemic COVID-19 positivity at the time of thrombectomy is associated with poor outcomes and tandem carotid pathology.

Thompson L, Houk C, Ellens N, Kohli G, Schartz D, Proper D Front Neurol. 2025; 16:1513124.

PMID: 40066309 PMC: 11891055. DOI: 10.3389/fneur.2025.1513124.


Acute Occlusion of a Persistent Sciatic Artery in a Patient with COVID-19 Infection.

Futagami D, Kobayashi T, Morimoto H, Kitaura J, Mukai S, Takahashi S Ann Vasc Dis. 2025; 18(1).

PMID: 40065903 PMC: 11891447. DOI: 10.3400/avd.cr.24-00126.


Development and validation of a nomogram to assess the occurrence of liver dysfunction in patients with COVID-19 pneumonia in the ICU.

Wang Z, Zhao L, Xie K BMC Infect Dis. 2025; 25(1):332.

PMID: 40065225 PMC: 11892215. DOI: 10.1186/s12879-025-10684-1.


Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19.

Lee J, Barnett S, Roberts K, Ashwin H, Milross L, Cho J Nat Commun. 2025; 16(1):1979.

PMID: 40064844 PMC: 11893906. DOI: 10.1038/s41467-025-56473-x.


References
1.
Anderson T, Meredith I, Yeung A, Frei B, Selwyn A, Ganz P . The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995; 332(8):488-93. DOI: 10.1056/NEJM199502233320802. View

2.
Bonetti P, Lerman L, Lerman A . Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003; 23(2):168-75. DOI: 10.1161/01.atv.0000051384.43104.fc. View

3.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

4.
Feldmann M, Maini R, Woody J, Holgate S, Winter G, Rowland M . Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet. 2020; 395(10234):1407-1409. PMC: 7158940. DOI: 10.1016/S0140-6736(20)30858-8. View

5.
Hurlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O . Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002; 106(17):2184-7. DOI: 10.1161/01.cir.0000037521.71373.44. View